This year, the FDA shed light on important, cross-cutting considerations for patient-level, real-world data to serve as an external control arm. Our new blog post highlights what you need to know - and the data you need to have - to conduct an externally controlled trial.

IgA nephropathy (IgAN) is a type of kidney disease that affects the glomeruli, the tiny filtering units within the kidneys. To diagnose and monitor IgAN, patients typically undergo a range of tests, including blood labs for kidney diseases, urine tests for kidney disease, and imaging studies.

CureDuchenne and PicnicHealth Announce Real-World Evidence-Focused Partnership to Incorporate Participant Medical Records into CureDuchenne Link

In the US, nearly two million kidney biopsies are performed each year at a rate of 175 procedures per million population. Kidney biopsies can reveal important information about kidney function and inform nephrologists about the possible cause of symptoms that brought the patient in for a visit in the first place.

Managing a chronic condition can be challenging, but there are tools to help patients monitor their health and manage their symptoms. From wearable health monitors to online medical record platforms, blood pressure monitors, symptom-tracking apps, and diet-tracking tools, patients have a variety of resources at their disposal. Here are six tools that can help you take control of your health and manage your IgA Nephropathy:

There are many organizations dedicated to helping patients with IgA nephropathy. Here are five of the top organizations that IgA nephropathy patients can turn to for support and resources.

The studies presented at the HTRS Scientific Symposium showcase some of the many ways PicnicHealth is partnering with leading researchers to deliver robust real-world evidence and improving patient care across different therapeutic areas, including rare diseases, hematology, immunology, neurology, and oncology

If you’ve been diagnosed with IgAN or suspect that you may have the disease, finding a knowledgeable and experienced nephrologist or IgAN specialist is crucial to managing your symptoms and receiving appropriate treatment. But where do you start?

PicnicHealth | Does a recent FDA approval signal changes for the wider industry when it comes to RWE?FDA approvals supported by Real-World Evidence (RWE) are rising. Life science companies would be remiss not to consider including evidence on the natural history of disease, unmet medical need, and/or patient-reported outcomes in their regulatory strategies. PicnicHealth has extensive experience helping life science companies execute strategies to leverage Real-World Data (RWD) and incorporate RWE into their research and business planning. Uncovering experiences and outcomes from real patients is at the heart of it all. Contact us to discuss how we can partner on confirmatory evidence studies to strengthen your regulatory submission.

IgA nephropathy (IgAN) is a kidney disease that can cause inflammation and damage to the kidneys due to the deposition of the immunoglobulin A (IgA) protein in the tiny filters in the kidneys, called ‘glomeruli’, which can lead to kidney dysfunction. The diagnostic process for IgAN usually involves a combination of tests to evaluate kidney function and determine the extent of damage.

A kidney transplant is a surgical procedure where a healthy kidney is placed into a patient whose kidneys no longer function properly. The healthy kidney comes from either a living or deceased donor. End-stage renal disease occurs when a patient’s kidneys lose the ability to filter fluid and waste from the body, leaving harmful levels of waste behind.

IgA Nephropathy (IgAN), also known as Berger’s disease, is a rare kidney disease that can cause issues with the kidneys’ ability to filter waste from the bloodstream. IgAN occurs when a compound called immunoglobulin A (IgA) builds up in excess within the kidneys, resulting in inflamed tissue and other complications. Thanks to modern treatment methods, IgAN can be effectively managed and its prognosis significantly improved. However, if left untreated, IgAN can lead to serious health problems, underscoring the importance of timely diagnosis and treatment.

The COVID-19 pandemic has had a significant impact on the lives of millions of people worldwide, including those with chronic conditions such as IgAN. Although there is limited research on the effects of COVID-19 on people with IgAN, it is crucial to take precautions and seek medical attention if you experience symptoms.

IgA nephropathy, also known as IgAN or Berger’s disease is a type of kidney disease that occurs when there is an excess build-up of immunoglobulin-A (IgA) within the kidneys. If left untreated, this can cause inflammation of the kidneys and other complications that reduce the kidneys’ ability to efficiently filter waste products from the bloodstream.

IgAN, or IgA nephropathy, is a chronic kidney disease affecting millions worldwide. Despite its prevalence, many patients struggle to understand the symptoms of IgAN and how to manage the condition effectively. ‍This is a problem that the team at PicnicHealth is working hard to solve. Founded by Noga Leviner in 2014, PicnicHealth was created by a fellow patient to empower others to take complete ownership of their health records and manage their conditions confidently. In this guide, we will explore the symptoms of IgAN, also known as Berger’s Disease, and provide helpful tips for managing the condition.

This webinar explores relevant examples of how Data Science and Digital Health are accelerating pharmaceutical innovation and driving impact for patients. Bringing together global experts with diverse perspectives spanning regulatory, R&D and health tech, this conversation highlights innovative, RWD-driven approaches to drug development and regulatory decision-making. Najat, Noga, Jesper, and Evelyn discuss the need for different types of data to construct a complete clinical picture – and how a data-driven approach can drive impact across both research and clinical practice.

Sometimes, my experience with IBM leaves me feeling amazed at how hard it is to figure everything out.

It’s important us PA parents keep using our voices to push for more research.

Our world had turned upside down, our ground had shifted below us, and we were trying to grasp at anything to hold on to.

We sat down with Evelyn Pyper, Senior Evidence Strategy Manager at PicnicHealth, to talk about successes, limitations, and areas for growth within the wearables industry.

PicnicHealth is launching a four-part webinar series that aims to reframe the “ROI” for RWE generation and tackle the question: beyond the return on investment for RWE, what is the risk of inaction?

At the heart of genetic counseling is empowering patients and families with knowledge of genetic disease and being a supportive pillar as they navigate their journeys.

2022 was the biggest and most exciting year yet for PicnicHealth - not only for our team, but for our Change Champions, PicnicHealth users, and research partners. We want to thank everyone for being a part of this incredible community and making this past year possible. Before we jump into 2023, join us as we look back at our favorite moments of last year. We raised $60 million in Series C funding! PicnicHealth is ecstatic to have raised a $60m Series C to help build deep, complete, and clinically-rich real-world datasets in several new diseases. The team spent the year growing our research program portfolio, connecting with new patient populations to initiate new studies; introducing new capabilities to our patient app to make it easier for patients to tell us more about their experiences by completing surveys, diaries, and more; and building new data features to help researchers gain new insights faster.

As a bleeding disorder, Hemophilia has the potential to create some serious problems for the patients that live with it every single day. Without the ability to properly clot your blood, it can be difficult to take many risks that could lead to excessive bleeding. Plus, this bleeding can occur internally at just about any time. This can significantly lower the patient’s overall quality of life, but there is a chance that it doesn’t have to be that way.

Mental health can mean a lot of different things to different people with seemingly vague definitions. MentalHealth.gov takes broad strokes to include emotional, psychological, and social well-being at the interface of how a person thinks, acts, and feels. Indicators that something is out of balance can present with a number of uncomfortable behaviors including having low or no energy, having unexplained aches or pains, or experiencing severe mood swings. It would be difficult to look through the entire list of possible symptoms and not relate at some level at some point in time, suggesting that mental wellness is just one fabric to the many layers that influence how we function on any given day. Unresolved or persistent mental health issues can lead to a diagnosis of mental illness, but it feels more fluid than other conditions or diseases that use more measurable diagnostic criteria such as abnormal lab values or imaging modalities to diagnose.